Cargando…
Low antithrombin levels are associated with low risk of cardiovascular death but are a risk factor for cancer mortality
BACKGROUND: Thrombosis is common in subjects suffering from cardiovascular diseases (CVD) and cancer. Hypercoagulation plays a pivotal role in the pathophysiology of thrombosis. Therefore, the inactivation of thrombin, the key enzyme in coagulation, is tightly regulated via antithrombin (AT). AT def...
Autores principales: | Iacoviello, Licia, de Laat-Kremers, Romy, Costanzo, Simona, Yan, Qiuting, Di Castelnuovo, Augusto, van der Vorm, Lisa, De Curtis, Amalia, Ninivaggi, Marisa, Cerletti, Chiara, Donati, Maria Benedetta, de Laat, Bas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484666/ https://www.ncbi.nlm.nih.gov/pubmed/36121817 http://dx.doi.org/10.1371/journal.pone.0271663 |
Ejemplares similares
-
Increased BMI and Blood Lipids Are Associated With a Hypercoagulable State in the Moli-sani Cohort
por: de Laat-Kremers, Romy, et al.
Publicado: (2022) -
Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation
por: de Laat-Kremers, Romy M. W., et al.
Publicado: (2021) -
Deciphering the coagulation profile through the dynamics of thrombin activity
por: de Laat-Kremers, Romy M. W., et al.
Publicado: (2020) -
Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assay
por: Carlo, Audrey, et al.
Publicado: (2022) -
ST Genesia reference values of 117 healthy donors measured with STG‐BleedScreen, STG‐DrugScreen and STG‐ThromboScreen reagents
por: Ninivaggi, Marisa, et al.
Publicado: (2020)